David S. Kinard - 27 Feb 2024 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Executive Vice President, Human Resources, Corporate Affairs and Administration
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for David S. Kinard
Issuer symbol
ELAN
Transactions as of
27 Feb 2024
Net transactions value
-$109,048
Form type
4
Filing time
29 Feb 2024, 18:27:37 UTC
Previous filing
06 Mar 2023
Next filing
05 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +14,562 +11% $0.000000 146,406 27 Feb 2024 Direct F1
transaction ELAN Common Stock Tax liability $109,048 -6,625 -4.5% $16.46 139,781 27 Feb 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 632 shares acquired on March 31, 2023, 591 shares acquired on June 30, 2023, 529 shares acquired on September 29, 2023 and 399 shares acquired on December 29, 2023, under Elanco Animal Health Inc.'s Employee Stock Purchase Plan .

Remarks:

Executive Vice President, Human Resources, Corporate Affairs and Administration